Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
2021 · iScience · 181 citations
https://doi.org/10.1016/j.isci.2021.102367
K
Katsumi Maenaka
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
399
Papers
10.7K
Citations
51
h-index
163
i10-index
Katsumi Maenaka is an academic researcher from Hokkaido University of Science. The author has contributed to research in topics: Immune Cell Function and Interaction & T-cell and B-cell Immunology & Virology and Viral Diseases. The author has an h-index of 51, co-authored 340 publications.
ORCID: 0000-0002-5459-521XPapers by this author
worksDynamic Interaction of the Measles Virus Hemagglutinin with Its Receptor Signaling Lymphocytic Activation Molecule (SLAM, CD150)
2008 · Journal of Biological Chemistry · 75 citations
https://doi.org/10.1074/jbc.m800896200
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
2021 · Immunity · 75 citations
https://doi.org/10.1016/j.immuni.2021.08.025
MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2
2021 · Scientific Reports · 34 citations
https://doi.org/10.1038/s41598-021-84882-7
Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia
2015 · Retrovirology · 23 citations
https://doi.org/10.1186/s12977-015-0225-x
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
2023 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-023-39890-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat